Salubris Biotherapeutics Announces $32 Million Financing to Advance Novel Complex Biologics for Cardiovascular, Oncology, and Neurodegenerative Diseases Read more
Jardiance (empagliflozin) becomes the first and only approved treatment in Europe for adults with symptomatic chronic heart failure regardless of ejection fraction Read more
Teva Announces Launch of a First Generic Version of Revlimid (lenalidomide capsules), in the U.S. Read more
Adagene Announces SAFEbody Multi-Target Collaboration with Sanofi for Novel Masked Immuno-Oncology Antibody Candidates Read more
FDA Approves Opdivo (nivolumab) with Chemotherapy as Neoadjuvant Treatment for Certain Adult Patients with Resectable Non-Small Cell Lung Cancer Read more
PURIFY’22 – Chromatography Purification Conclave Promises to Provide Unprecedented Knowledge and Networking Opportunities Read more
BeiGene Announces Health Canada Approval for BRUKINSA (zanubrutinib) in Relapsed or Refractory Marginal Zone Lymphoma Read more